We use cookies for a better user experience. Read our Privacy Policy

I Agree

Cell & Tissue Preservation Market Forecast Report, 2021-2031

Cell & Tissue Preservation Market (Type: Cells and Tissues; Application: Therapeutics, Research & Development, Drug Discovery, and Others; Product: Equipment, Bio Preservation Media, and Software; and End User: Biobanks, Hospitals, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Implementation of Risk-mitigation Strategies at Fertility Centers amidst COVID-19 Pandemic

The reopening of fertility care services in the midst of the COVID-19 pandemic lead to numerous concerns that need immediate addressing. Companies in the cell & tissue preservation market are gaining awareness about these concerns to prevent the risk of cross-contamination and transmission at the fertility centers. Due to the novelty of the disease, there is a need for more information confirming an association of coronavirus with reproductive tissues, embryos, and gametes.

Cryobanking, being an essential service in fertility preservation, is linked with the risk of cross-contamination through the cryogenic mediums. Stakeholders are increasing research to find possible sources of cross-contamination through liquid nitrogen.

cell & tissue preservation market infographic

Request a sample to get extensive insights into the Cell & Tissue Preservation Market

Ice-related Damage in Tissues Creates Drawbacks in Cryopreservation

Cryopreservation holds potential to strongly benefit several areas of medicine by increasing the ease with which therapeutic cells, tissues, and organs can be stored. However, it has been found that extracellular ice directly damages tissues, either by puncturing or crushing cell membranes or by disrupting extracellular structures. In order to reduce the extent of ice-related damage, stakeholders are making use of cryopreservation protocols such as the CPAs (cryoprotective agents).

CPAs help to reduce the concentration of electrolytes and ice formation by hydrogen bonding with water molecules to prevent them from bonding to ice crystals. CPAs capable of crossing cell membranes are crucial in cryopreservation. The use of such molecules, termed penetrating CPAs (pCPAs), can substantially reduce cryoinjury.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Application of Oxygen in Preservation of Transplant Organs Gains Popularity

The cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031. Giner Life Sciences - a privately-held company focused on the development and commercialization of oxygenated cell therapies, is pursuing new approaches in the application of oxygen for the preservation of transplant organs and clusters of cells inside implantable capsules. Companies in the cell & tissue preservation market are taking cues from such innovative approaches to develop transportation devices for a donated pancreas organ, which incorporates an on-demand oxygen generator.

Transportation device incorporating an on-demand oxygen generator holds potential to supply oxygen to the vasculature of the pancreas as soon as possible after it is donated.

Toxicity of DMSO Leads to Innovations in Biomimetic Materials

There is a need for mid-range automation for cryopreservation. Companies in the cell & tissue preservation market are innovating in robot in order to meet this demand. Though dimethyl sulfoxide (DMSO) is considered as the gold standard for cryopreservation of mammalian cells and tissues, certain concentrations of DMSO can be toxic to cells. Thus, to mitigate potential toxicity problems, companies in the cell & tissue preservation market are increasing research on using different combinations of cryoprotective agents such as supplementing a lower concentration of DMSO with the glycerol or polypropylene glycol.

Moreover, companies are increasing efforts to introduce alternatives to DMSO such as biomimetic materials that are called the antifreeze protein or an ice-binding protein.

cell & tissue preservation market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Cell & Tissue Preservation Market

Analysts’ Viewpoint

Companies in the cell & tissue preservation market are adopting strategies to reduce the risks of cross-contamination at fertility centers, especially for oncofertility, amid the COVID-19 pandemic.. The cell & tissue preservation market is expected to reach US$ 10.04 Bn by 2031. However, one of the main limitations of current cryopreservation methods is the recovery rate of cells after freezing. Hence, companies should increase research in antifreeze proteins that have the potential to mimic the properties of synthetic polymers in cryopreservation methods. In addition, transportation devices incorporating on-demand oxygen generator are being publicized for use in organ transplant applications.

Cell & Tissue Preservation Market: Overview

  • Cell & tissue banks are biorepositories for the preservation of human and animal cells & tissues utilized for biodiversity studies, disease diagnosis, and research. These banks assist in the storage of various types of tissue samples such as bone, skin, cornea, heart valves, umbilical cord, and human soft tissues.
  • Cell & tissue banks vary significantly in size, with cell & tissue banks in medical institutions storing a moderate number of samples, while national tissue banks store a large number of samples. These samples are utilized to support research, particularly studies in personalized medicine, genetic disorders, and stem cell research to treat genetic conditions and maintain and update age demographic databases.
  • Increasing demand for regenerative medicines is a significant factor driving the global cell & tissue preservation market. These medicines are capable of replacing, engineering, and regenerating functional cells, tissues for treating tissue loss due to age-related diseases or conditions, diseases, major injury, or congenital defects.
  • Other vital factors driving the market include increasing prevalence of cardiovascular and neurological disorders, a variety of cancers, diabetes, and other diseases
  • Increasing need for storage of organs for transplant and research of new patient medicines in research center initiatives by healthcare organizations to improvise healthcare facilities are anticipated to fuel the global cell & tissue preservation market

Market Segmentation: Cell & Tissue Preservation Market

  • In terms of type, the global cell & tissue preservation market has been classified into cells and tissues. Cells have been split into mammalian cells & others (microorganisms and plant cells). The tissues segment has been categorized into blood, bone, soft tissues, skin, and others. Rise in investments in the field of regenerative medicine research is estimated to propel the market. Human blood, tissues, cells, and organs own the capability to heal damaged tissues and organs with long-term advantages.
  • Based on application, the global cell & tissue preservation market has been divided into therapeutics, research & development, drug discovery, and others. Tissues preserved in tissue banks could be utilized to fulfill a variety of medical needs of people. For instance, heart valves can be used in patients with heart disorders; corneal transplantation can be used to provide vision to blind people; tendons and ligaments can be used in orthopedic surgery; and blood can be employed to treat blood disorders.
  • In terms of product, the global cell & tissue preservation market has been divided into equipment, bio preservation media, and software. The equipment segment has been further sub-segmented into freezers, thawing equipment, refrigerators, storage systems, and others. While the bio preservation media segment has been further classified into home-brew media and pre-formulated media. In terms of equipment type, the cryopreservation systems segment dominated the market in 2020. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities that are to be used for procedures such as organ donation, bone marrow transplant, and others.
  • Based on end user, the global cell & tissue preservation market has been segmented into biobanks, hospitals, and others. Biobanks store numerous different types of biospecimens, ranging from cells and small tissue samples right through to whole organs, whole limbs, or even whole bodies. Cells and small biospecimens could be flash frozen in cryoprotectant solutions and stored in liquid nitrogen to preserve their structure and function.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The cell & tissue preservation market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Regional Overview: Cell & Tissue Preservation Market

  • In terms of region, the global cell & tissue preservation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and expected market value (US$ Mn) of these regional markets and their major countries have been provided in the report from 2021 to 2031, with their CAGRs from 2021 to 2031
  • The study also offers a list of recommendations, highlights, and useful insights of the global cell & tissue preservation market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process

Major Players

  • The cell & tissue preservation market report concludes with the company profiles section, which includes key information about major players in the global cell & tissue preservation market
  • Leading players analyzed in the report include
    • Thermo Fisher Scientific, Inc.
    • Lonza
    • BD
    • Merck KGaA
    • Cytiva
    • Agilent Technologies, Inc.
    • Avantor, Inc.
    • FUJIFILM Irvine Scientific
    • BioLifeSolutions Inc.
    • AMSBIO
    • Princeton CryoTech
    • STEMCELL Technologies Inc.
    • LGC SeraCare
    • Corning Incorporated
    • CellGenix GmbH
  • Each of these players has been profiled in the cell & tissue preservation market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Cell & Tissue Preservation Market – Segmentation

TMR’s study on the global cell & tissue preservation market includes information divided into five segments: type, application, product, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global cell & tissue preservation market are discussed in detail.

Type
  • Cells
    • Mammalian Cells
    • Others (Microorganisms and Plant Cells)
  • Tissues
    • Blood
    • Bone
    • Soft Tissues
    • Skin
    • Others
Product
  • Software
  • Equipment
    • Freezers
    • Refrigerators
    • Storage Systems
    • Others
  • Bio Preservation Media
    • Home-brew Media
    • Pre-formulated Media
End User
  • Biobanks
  • Hospitals
  • Others
Application
  • Therapeutics
  • Research & Development
  • Drug Discovery
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Cell & Tissue Preservation Market Forecast Report, 2021-2031

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of cell & tissue preservation market?

Cell & tissue preservation market to reach valuation Of US$ 10.04 Bn by 2031

What is the anticipated CAGR of the cell & tissue preservation market in the forecast period?

Cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031

What are the key driving factors for the growth of the cell & tissue preservation market?

Cell & tissue preservation market is driven by increasing demand for regenerative medicines

What are the end-use segments in the cell & tissue preservation market?

The end-use segments in cell & tissue preservation market are biobanks, hospitals & others

Who are the key players in the global cell & tissue preservation market?

Key players operating in the global cell & tissue market include Thermo Fisher Scientific, Inc., Lonza, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cell & Tissue Preservation Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cell & Tissue Preservation Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)

    5.2. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)

    5.3. Process Analysis

    5.4. Top companies operating in Market Space

    5.5. Applications of cell & tissue culture in drug development

    5.6. Technological Advancements

6. Global Cell & Tissue Preservation Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

        6.3.1. Cells

            6.3.1.1. Mammalian Cells

            6.3.1.2. Others (microorganisms and plant cells)

        6.3.2. Tissues

            6.3.2.1. Blood

            6.3.2.2. Bone

            6.3.2.3. Soft Tissues

            6.3.2.4. Skin

            6.3.2.5. Others

    6.4. Global Cell & Tissue Preservation Market Attractiveness, by Type

7. Global Cell & Tissue Preservation Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

        7.3.1. Therapeutics

        7.3.2. Research & Development

        7.3.3. Drug Discovery

        7.3.4. Others (Cosmetics and Clinical trials)

    7.4. Global Cell & Tissue Preservation Market Attractiveness, by Application

8. Global Cell & Tissue Preservation Market Analysis and Forecast, by Product

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

        8.3.1. Equipment

            8.3.1.1. Freezers

            8.3.1.2. Thawing Equipment

            8.3.1.3. Refrigerators

            8.3.1.4. Storage Systems

            8.3.1.5. Others

        8.3.2. Bio preservation media

            8.3.2.1. Home-brew media

            8.3.2.2. Pre-formulated media

        8.3.3. Software

    8.4. Global Cell & Tissue Preservation Market Attractiveness, by Product

9. Global Cell & Tissue Preservation Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Global Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

        9.3.1. Biobanks

        9.3.2. Hospitals

        9.3.3. Others

    9.4. Global Cell & Tissue Preservation Market Attractiveness, by End-user

10. Global Cell & Tissue Preservation Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Global Cell & Tissue Preservation Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Global Cell & Tissue Preservation Market Attractiveness, by Region

11. North America Cell & Tissue Preservation Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. North America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

        11.2.1. Cells

            11.2.1.1. Mammalian Cells

            11.2.1.2. Others (microorganisms and plant cells)

        11.2.2. Tissues

            11.2.2.1. Blood

            11.2.2.2. Bone

            11.2.2.3. Soft Tissues

            11.2.2.4. Skin

            11.2.2.5. Others

    11.3. North America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

        11.3.1. Therapeutics

        11.3.2. Research & Development

        11.3.3. Drug Discovery

        11.3.4. Others (Cosmetics and Clinical trials)

    11.4. North America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

        11.4.1. Equipment

            11.4.1.1. Freezers

            11.4.1.2. Thawing Equipment

            11.4.1.3. Refrigerators

            11.4.1.4. Storage Systems

            11.4.1.5. Others

        11.4.2. Bio preservation media

            11.4.2.1. Home-brew media

            11.4.2.2. Pre-formulated media

        11.4.3. Software

    11.5. North America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

        11.5.1. Biobanks

        11.5.2. Hospitals

        11.5.3. Others

    11.6. North America Cell & Tissue Preservation Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Cell & Tissue Preservation Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By Application

        11.7.3. By Product

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Cell & Tissue Preservation Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

        12.2.1. Cells

            12.2.1.1. Mammalian Cells

            12.2.1.2. Others (microorganisms and plant cells)

        12.2.2. Tissues

            12.2.2.1. Blood

            12.2.2.2. Bone

            12.2.2.3. Soft Tissues

            12.2.2.4. Skin

            12.2.2.5. Others

    12.3. Europe Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

        12.3.1. Therapeutics

        12.3.2. Research & Development

        12.3.3. Drug Discovery

        12.3.4. Others (Cosmetics and Clinical trials)

    12.4. Europe Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

        12.4.1. Equipment

            12.4.1.1. Freezers

            12.4.1.2. Thawing Equipment

            12.4.1.3. Refrigerators

            12.4.1.4. Storage Systems

            12.4.1.5. Others

        12.4.2. Bio preservation media

            12.4.2.1. Home-brew media

            12.4.2.2. Pre-formulated media

        12.4.3. Software

    12.5. Europe Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

        12.5.1. Biobanks

        12.5.2. Hospitals

        12.5.3. Others

    12.6. Europe Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Cell & Tissue Preservation Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By Application

        12.7.3. By Product

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Cell & Tissue Preservation Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

        13.2.1. Cells

            13.2.1.1. Mammalian Cells

            13.2.1.2. Others (microorganisms and plant cells)

        13.2.2. Tissues

            13.2.2.1. Blood

            13.2.2.2. Bone

            13.2.2.3. Soft Tissues

            13.2.2.4. Skin

            13.2.2.5. Others

    13.3. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

        13.3.1. Therapeutics

        13.3.2. Research & Development

        13.3.3. Drug Discovery

        13.3.4. Others (Cosmetics and Clinical trials)

    13.4. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

        13.4.1. Equipment

            13.4.1.1. Freezers

            13.4.1.2. Thawing Equipment

            13.4.1.3. Refrigerators

            13.4.1.4. Storage Systems

            13.4.1.5. Others

        13.4.2. Bio preservation media

            13.4.2.1. Home-brew media

            13.4.2.2. Pre-formulated media

        13.4.3. Software

    13.5. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

        13.5.1. Biobanks

        13.5.2. Hospitals

        13.5.3. Others

    13.6. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By Application

        13.7.3. By Product

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Cell & Tissue Preservation Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Latin America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

        14.2.1. Cells

            14.2.1.1. Mammalian Cells

            14.2.1.2. Others (microorganisms and plant cells)

        14.2.2. Tissues

            14.2.2.1. Blood

            14.2.2.2. Bone

            14.2.2.3. Soft Tissues

            14.2.2.4. Skin

            14.2.2.5. Others

    14.3. Latin America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

        14.3.1. Therapeutics

        14.3.2. Research & Development

        14.3.3. Drug Discovery

        14.3.4. Others (Cosmetics and Clinical trials)

    14.4. Latin America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

        14.4.1. Equipment

            14.4.1.1. Freezers

            14.4.1.2. Thawing Equipment

            14.4.1.3. Refrigerators

            14.4.1.4. Storage Systems

            14.4.1.5. Others

        14.4.2. Bio preservation media

            14.4.2.1. Home-brew media

            14.4.2.2. Pre-formulated media

        14.4.3. Software

    14.5. Latin America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

        14.5.1. Biobanks

        14.5.2. Hospitals

        14.5.3. Others

    14.6. Latin America Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By Application

        14.7.3. By Product

        14.7.4. By End-user

        14.7.5. By Country

15. Middle East & Africa Cell & Tissue Preservation Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

        15.2.1. Cells

            15.2.1.1. Mammalian Cells

            15.2.1.2. Others (microorganisms and plant cells)

        15.2.2. Tissues

            15.2.2.1. Blood

            15.2.2.2. Bone

            15.2.2.3. Soft Tissues

            15.2.2.4. Skin

            15.2.2.5. Others

    15.3. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

        15.3.1. Therapeutics

        15.3.2. Research & Development

        15.3.3. Drug Discovery

        15.3.4. Others (Cosmetics and Clinical trials)

    15.4. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

        15.4.1. Equipment

            15.4.1.1. Freezers

            15.4.1.2. Thawing Equipment

            15.4.1.3. Refrigerators

            15.4.1.4. Storage Systems

            15.4.1.5. Others

        15.4.2. Bio preservation media

            15.4.2.1. Home-brew media

            15.4.2.2. Pre-formulated media

        15.4.3. Software

    15.5. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

        15.5.1. Biobanks

        15.5.2. Hospitals

        15.5.3. Others

    15.6. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis

        15.7.1. By Type

        15.7.2. By Application

        15.7.3. By Product

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Share Analysis, by Company (2019)

    16.2. Company Profiles

        16.2.1. Thermo Fisher Scientific, Inc.

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Product Portfolio

            16.2.1.3. SWOT Analysis

            16.2.1.4. Strategic Overview

        16.2.2. Lonza

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Product Portfolio

            16.2.2.3. SWOT Analysis

            16.2.2.4. Strategic Overview

        16.2.3. BD

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Product Portfolio

            16.2.3.3. SWOT Analysis

            16.2.3.4. Strategic Overview

        16.2.4. Merck KGaA

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Product Portfolio

            16.2.4.3. SWOT Analysis

            16.2.4.4. Strategic Overview

        16.2.5. Cytiva

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Product Portfolio

            16.2.5.3. SWOT Analysis

            16.2.5.4. Strategic Overview

        16.2.6. Agilent Technologies, Inc.

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Product Portfolio

            16.2.6.3. SWOT Analysis

            16.2.6.4. Strategic Overview

        16.2.7. Avantor, Inc.

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Product Portfolio

            16.2.7.3. SWOT Analysis

            16.2.7.4. Strategic Overview

        16.2.8. FUJIFILM Irvine Scientific.

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Product Portfolio

            16.2.8.3. SWOT Analysis

            16.2.8.4. Strategic Overview

        16.2.9. BioLifeSolutions Inc.

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Product Portfolio

            16.2.9.3. SWOT Analysis

            16.2.9.4. Strategic Overview

        16.2.10. AMSBIO

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Product Portfolio

            16.2.10.3. SWOT Analysis

            16.2.10.4. Strategic Overview

        16.2.11. Princeton CryoTech

            16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.11.2. Product Portfolio

            16.2.11.3. SWOT Analysis

            16.2.11.4. Strategic Overview

        16.2.12. STEMCELL Technologies Inc.

            16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.12.2. Product Portfolio

            16.2.12.3. SWOT Analysis

            16.2.12.4. Strategic Overview

        16.2.13. LGC SeraCare

            16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.13.2. Product Portfolio

            16.2.13.3. SWOT Analysis

            16.2.13.4. Strategic Overview

        16.2.14. Corning Incorporated

            16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.14.2. Product Portfolio

            16.2.14.3. SWOT Analysis

            16.2.14.4. Strategic Overview

        16.2.15. CellGenix GmbH

            16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.15.2. Product Portfolio

            16.2.15.3. SWOT Analysis

            16.2.15.4. Strategic Overview

        16.2.16. Others

            16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.16.2. Product Portfolio

            16.2.16.3. SWOT Analysis

            16.2.16.4. Strategic Overview

List of Tables

Table 01: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

Table 03: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

Table 04: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 05: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 06: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 07: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

Table 08: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 10: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 12: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

Table 13: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

Table 14: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 16: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 17: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

Table 18: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 21: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

Table 22: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

Table 23: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 25: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 26: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

Table 27: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 28: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 29: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 30: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

Table 31: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

Table 32: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 33: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 34: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 35: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

Table 36: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 37: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 38: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 39: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

Table 40: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

Table 41: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 42: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 43: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 44: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

Table 45: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 46: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 47: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 48: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

Table 49: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

Table 50: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 51: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 52: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 53: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

Table 54: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Cell & Tissue Preservation Market Value Share, by Type, 2020

Figure 03: Global Cell & Tissue Preservation Market Value Share, by Product, 2020

Figure 04: Global Cell & Tissue Preservation Market Value Share, by Application, 2020

Figure 05: Global Cell & Tissue Preservation Market Value Share, by Region, 2020

Figure 06: Global Cell & Tissue Preservation Market Value Share, by End-user, 2020

Figure 07: Global Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

Figure 08: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

Figure 09: Global Cell & Tissue Preservation Market Value (US$ Mn), by Cells, 2017–2031

Figure 10: Global Cell & Tissue Preservation Market Value (US$ Mn), by Tissues, 2017–2031

Figure 11: Global Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

Figure 12: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

Figure 13: Global Cell & Tissue Preservation Market Value (US$ Mn), by Therapeutics, 2017–2031

Figure 14: Global Cell & Tissue Preservation Market Value (US$ Mn), by Research & Development, 2017–2031

Figure 15: Global Cell & Tissue Preservation Market Value (US$ Mn), by Drug Discovery, 2017–2031

Figure 16: Global Cell & Tissue Preservation Market Value (US$ Mn), by Others (Cosmetics and Clinical trials), 2017–2031

Figure 17: Global Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

Figure 18: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

Figure 19: Global Cell & Tissue Preservation Market Value (US$ Mn), by Equipment, 2017–2031

Figure 20: Global Cell & Tissue Preservation Market Value (US$ Mn), by Bio Preservation Media, 2017–2031

Figure 21: Global Cell & Tissue Preservation Market Value (US$ Mn), by Software, 2017–2031

Figure 22: Global Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

Figure 23: Global Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

Figure 24: Global Cell & Tissue Preservation Market Value (US$ Mn), by Biobanks, 2017–2031

Figure 25: Global Cell & Tissue Preservation Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 26: Global Cell & Tissue Preservation Market Value (US$ Mn), by Others, 2017–2031

Figure 27: Global Cell & Tissue Preservation Market Value Share Analysis, by Region, 2020 and 2031

Figure 28: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Region, 2021–2031

Figure 29: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 30: North America Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

Figure 31: North America Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 32: North America Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

Figure 33: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

Figure 34: North America Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

Figure 35: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

Figure 36: North America Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

Figure 37: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

Figure 38: North America Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

Figure 39: North America Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

Figure 40: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 41: Europe Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

Figure 42: Europe Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 43: Europe Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

Figure 44: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

Figure 45: Europe Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

Figure 46: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

Figure 47: Europe Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

Figure 48: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

Figure 49: Europe Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

Figure 50: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

Figure 51: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 52: Asia Pacific Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

Figure 53: Asia Pacific Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 54: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

Figure 55: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

Figure 56: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

Figure 57: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

Figure 58: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

Figure 59: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

Figure 60: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

Figure 61: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

Figure 62: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 63: Latin America Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

Figure 64: Latin America Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 65: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

Figure 66: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

Figure 67: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

Figure 68: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

Figure 69: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

Figure 70: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

Figure 71: Latin America Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

Figure 72: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

Figure 73: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 74: Middle East & Africa Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

Figure 75: Middle East & Africa Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 76: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

Figure 77: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

Figure 78: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

Figure 79: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

Figure 80: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

Figure 81: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

Figure 82: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

Figure 83: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

Figure 84: Global Cell & Tissue Preservation Market Share, by Company, 2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

786

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved